PharmaEssentia Corporation

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023

In its 2023 reporting, PharmaEssentia Corporation disclosed greenhouse gas emissions of Less than 5,000 metric tons of CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
Less than 5,000 metric tons of CO2e
2023
♻️
Waste
33.8 metric tons
2023

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce water consumption
  • Achieve net-zero emissions by 2050
  • Implement ISO 14001 Environmental Management System
  • Obtain ISO 27001 Certification

📅 Medium-term

  • Achieve 30% renewable energy
  • Implement a Data Management Platform (DMP) for File Encryption

🔭 Long-term

  • Net zero emissions by 2050

🌱 ESG Focus Areas

Corporate GovernanceEnvironmental SustainabilityDrug Quality and SafetyEmployee Well-beingPatient Access

⚠️ Challenges & Risks +

  • Supply chain disruptions due to climate events
  • Transition risks from regulatory changes and market shifts related to climate change
  • Potential financial losses from carbon fees and energy-related taxes
  • Potential material shortages and increased transportation costs due to climate change
  • Potential operational interruptions due to natural disasters

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards (General Standard 2021), SASB Biotechnology industry standards, TCFD, UN Global Compact, AA1000 Type 1
Assurance: AFNOR Asia Ltd (Moderate Assurance)